- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.05 Å
- Oligo State
- homo-24-mer
- Ligands
- 48 x FE2: FE (II) ION(Non-covalent)
- 90 x SO4: SULFATE ION(Non-functional Binders)
SO4.3: 5 residues within 4Å:- Chain A: K.50, S.162, S.163, T.164, G.165
Ligand excluded by PLIPSO4.4: 2 residues within 4Å:- Chain A: S.144, N.148
Ligand excluded by PLIPSO4.5: 3 residues within 4Å:- Chain A: P.161, S.162, S.163
Ligand excluded by PLIPSO4.7: 6 residues within 4Å:- Chain A: T.76, Q.77
- Chain B: K.78, G.80, K.81, V.82
Ligand excluded by PLIPSO4.10: 4 residues within 4Å:- Chain B: K.50, S.163, T.164
- Ligands: FEC.6
Ligand excluded by PLIPSO4.11: 2 residues within 4Å:- Chain B: S.144, N.148
Ligand excluded by PLIPSO4.12: 3 residues within 4Å:- Chain B: K.114
- Chain C: K.114
- Chain H: K.114
Ligand excluded by PLIPSO4.13: 3 residues within 4Å:- Chain B: P.161, S.162, S.163
Ligand excluded by PLIPSO4.16: 4 residues within 4Å:- Chain C: K.50, S.162, S.163, T.164
Ligand excluded by PLIPSO4.17: 2 residues within 4Å:- Chain C: S.144, N.148
Ligand excluded by PLIPSO4.18: 3 residues within 4Å:- Chain C: P.161, S.162, S.163
Ligand excluded by PLIPSO4.22: 6 residues within 4Å:- Chain D: K.50, S.162, S.163, T.164, G.165
- Ligands: FEC.19
Ligand excluded by PLIPSO4.23: 2 residues within 4Å:- Chain D: N.4, R.5
Ligand excluded by PLIPSO4.24: 2 residues within 4Å:- Chain D: S.144, N.148
Ligand excluded by PLIPSO4.25: 3 residues within 4Å:- Chain D: P.161, S.162, S.163
Ligand excluded by PLIPSO4.26: 3 residues within 4Å:- Chain D: K.114
- Chain E: K.114
- Chain W: K.114
Ligand excluded by PLIPSO4.29: 3 residues within 4Å:- Chain E: K.50, T.164, G.165
Ligand excluded by PLIPSO4.30: 2 residues within 4Å:- Chain E: N.4, R.5
Ligand excluded by PLIPSO4.31: 3 residues within 4Å:- Chain E: S.144, K.147, N.148
Ligand excluded by PLIPSO4.32: 3 residues within 4Å:- Chain E: P.161, S.162, S.163
Ligand excluded by PLIPSO4.36: 5 residues within 4Å:- Chain F: K.50, S.163, T.164, G.165
- Ligands: FEC.33
Ligand excluded by PLIPSO4.37: 5 residues within 4Å:- Chain F: K.114
- Chain N: K.114
- Chain V: K.114
- Ligands: SO4.87, SO4.137
Ligand excluded by PLIPSO4.38: 3 residues within 4Å:- Chain F: P.161, S.162, S.163
Ligand excluded by PLIPSO4.41: 5 residues within 4Å:- Chain G: K.50, S.162, S.163, T.164, G.165
Ligand excluded by PLIPSO4.42: 3 residues within 4Å:- Chain G: N.4, R.5, E.6
Ligand excluded by PLIPSO4.43: 3 residues within 4Å:- Chain G: S.144, K.147, N.148
Ligand excluded by PLIPSO4.44: 3 residues within 4Å:- Chain G: P.161, S.162, S.163
Ligand excluded by PLIPSO4.48: 5 residues within 4Å:- Chain H: K.50, S.162, S.163, T.164, G.165
Ligand excluded by PLIPSO4.49: 2 residues within 4Å:- Chain H: S.144, N.148
Ligand excluded by PLIPSO4.50: 3 residues within 4Å:- Chain H: P.161, S.162, S.163
Ligand excluded by PLIPSO4.53: 5 residues within 4Å:- Chain I: K.50, S.162, S.163, T.164, G.165
Ligand excluded by PLIPSO4.54: 2 residues within 4Å:- Chain I: S.144, N.148
Ligand excluded by PLIPSO4.55: 3 residues within 4Å:- Chain I: P.161, S.162, S.163
Ligand excluded by PLIPSO4.57: 6 residues within 4Å:- Chain I: T.76, Q.77
- Chain J: K.78, G.80, K.81, V.82
Ligand excluded by PLIPSO4.60: 4 residues within 4Å:- Chain J: K.50, S.163, T.164
- Ligands: FEC.56
Ligand excluded by PLIPSO4.61: 2 residues within 4Å:- Chain J: S.144, N.148
Ligand excluded by PLIPSO4.62: 3 residues within 4Å:- Chain J: K.114
- Chain K: K.114
- Chain P: K.114
Ligand excluded by PLIPSO4.63: 3 residues within 4Å:- Chain J: P.161, S.162, S.163
Ligand excluded by PLIPSO4.66: 4 residues within 4Å:- Chain K: K.50, S.162, S.163, T.164
Ligand excluded by PLIPSO4.67: 2 residues within 4Å:- Chain K: S.144, N.148
Ligand excluded by PLIPSO4.68: 3 residues within 4Å:- Chain K: P.161, S.162, S.163
Ligand excluded by PLIPSO4.72: 6 residues within 4Å:- Chain L: K.50, S.162, S.163, T.164, G.165
- Ligands: FEC.69
Ligand excluded by PLIPSO4.73: 2 residues within 4Å:- Chain L: N.4, R.5
Ligand excluded by PLIPSO4.74: 2 residues within 4Å:- Chain L: S.144, N.148
Ligand excluded by PLIPSO4.75: 3 residues within 4Å:- Chain L: P.161, S.162, S.163
Ligand excluded by PLIPSO4.76: 3 residues within 4Å:- Chain G: K.114
- Chain L: K.114
- Chain M: K.114
Ligand excluded by PLIPSO4.79: 3 residues within 4Å:- Chain M: K.50, T.164, G.165
Ligand excluded by PLIPSO4.80: 2 residues within 4Å:- Chain M: N.4, R.5
Ligand excluded by PLIPSO4.81: 3 residues within 4Å:- Chain M: S.144, K.147, N.148
Ligand excluded by PLIPSO4.82: 3 residues within 4Å:- Chain M: P.161, S.162, S.163
Ligand excluded by PLIPSO4.86: 5 residues within 4Å:- Chain N: K.50, S.163, T.164, G.165
- Ligands: FEC.83
Ligand excluded by PLIPSO4.87: 5 residues within 4Å:- Chain F: K.114
- Chain N: K.114
- Chain V: K.114
- Ligands: SO4.37, SO4.137
Ligand excluded by PLIPSO4.88: 3 residues within 4Å:- Chain N: P.161, S.162, S.163
Ligand excluded by PLIPSO4.91: 5 residues within 4Å:- Chain O: K.50, S.162, S.163, T.164, G.165
Ligand excluded by PLIPSO4.92: 3 residues within 4Å:- Chain O: N.4, R.5, E.6
Ligand excluded by PLIPSO4.93: 3 residues within 4Å:- Chain O: S.144, K.147, N.148
Ligand excluded by PLIPSO4.94: 3 residues within 4Å:- Chain O: P.161, S.162, S.163
Ligand excluded by PLIPSO4.98: 5 residues within 4Å:- Chain P: K.50, S.162, S.163, T.164, G.165
Ligand excluded by PLIPSO4.99: 2 residues within 4Å:- Chain P: S.144, N.148
Ligand excluded by PLIPSO4.100: 3 residues within 4Å:- Chain P: P.161, S.162, S.163
Ligand excluded by PLIPSO4.103: 5 residues within 4Å:- Chain Q: K.50, S.162, S.163, T.164, G.165
Ligand excluded by PLIPSO4.104: 2 residues within 4Å:- Chain Q: S.144, N.148
Ligand excluded by PLIPSO4.105: 3 residues within 4Å:- Chain Q: P.161, S.162, S.163
Ligand excluded by PLIPSO4.107: 6 residues within 4Å:- Chain Q: T.76, Q.77
- Chain R: K.78, G.80, K.81, V.82
Ligand excluded by PLIPSO4.110: 4 residues within 4Å:- Chain R: K.50, S.163, T.164
- Ligands: FEC.106
Ligand excluded by PLIPSO4.111: 2 residues within 4Å:- Chain R: S.144, N.148
Ligand excluded by PLIPSO4.112: 3 residues within 4Å:- Chain R: K.114
- Chain S: K.114
- Chain X: K.114
Ligand excluded by PLIPSO4.113: 3 residues within 4Å:- Chain R: P.161, S.162, S.163
Ligand excluded by PLIPSO4.116: 4 residues within 4Å:- Chain S: K.50, S.162, S.163, T.164
Ligand excluded by PLIPSO4.117: 2 residues within 4Å:- Chain S: S.144, N.148
Ligand excluded by PLIPSO4.118: 3 residues within 4Å:- Chain S: P.161, S.162, S.163
Ligand excluded by PLIPSO4.122: 6 residues within 4Å:- Chain T: K.50, S.162, S.163, T.164, G.165
- Ligands: FEC.119
Ligand excluded by PLIPSO4.123: 2 residues within 4Å:- Chain T: N.4, R.5
Ligand excluded by PLIPSO4.124: 2 residues within 4Å:- Chain T: S.144, N.148
Ligand excluded by PLIPSO4.125: 3 residues within 4Å:- Chain T: P.161, S.162, S.163
Ligand excluded by PLIPSO4.126: 3 residues within 4Å:- Chain O: K.114
- Chain T: K.114
- Chain U: K.114
Ligand excluded by PLIPSO4.129: 3 residues within 4Å:- Chain U: K.50, T.164, G.165
Ligand excluded by PLIPSO4.130: 2 residues within 4Å:- Chain U: N.4, R.5
Ligand excluded by PLIPSO4.131: 3 residues within 4Å:- Chain U: S.144, K.147, N.148
Ligand excluded by PLIPSO4.132: 3 residues within 4Å:- Chain U: P.161, S.162, S.163
Ligand excluded by PLIPSO4.136: 5 residues within 4Å:- Chain V: K.50, S.163, T.164, G.165
- Ligands: FEC.133
Ligand excluded by PLIPSO4.137: 5 residues within 4Å:- Chain F: K.114
- Chain N: K.114
- Chain V: K.114
- Ligands: SO4.37, SO4.87
Ligand excluded by PLIPSO4.138: 3 residues within 4Å:- Chain V: P.161, S.162, S.163
Ligand excluded by PLIPSO4.141: 5 residues within 4Å:- Chain W: K.50, S.162, S.163, T.164, G.165
Ligand excluded by PLIPSO4.142: 3 residues within 4Å:- Chain W: N.4, R.5, E.6
Ligand excluded by PLIPSO4.143: 3 residues within 4Å:- Chain W: S.144, K.147, N.148
Ligand excluded by PLIPSO4.144: 3 residues within 4Å:- Chain W: P.161, S.162, S.163
Ligand excluded by PLIPSO4.148: 5 residues within 4Å:- Chain X: K.50, S.162, S.163, T.164, G.165
Ligand excluded by PLIPSO4.149: 2 residues within 4Å:- Chain X: S.144, N.148
Ligand excluded by PLIPSO4.150: 3 residues within 4Å:- Chain X: P.161, S.162, S.163
Ligand excluded by PLIP- 12 x FEC: 1,3,5,8-TETRAMETHYL-PORPHINE-2,4,6,7-TETRAPROPIONIC ACID FERROUS COMPLEX(Non-covalent)
FEC.6: 20 residues within 4Å:- Chain A: R.20, L.24, H.28, M.31, Y.35, K.50, M.57, E.61, S.168
- Chain B: R.20, I.27, H.28, M.31, Y.35, K.50, M.57, E.61, A.167, S.168
- Ligands: SO4.10
17 PLIP interactions:10 interactions with chain B, 7 interactions with chain A,- Hydrophobic interactions: B:I.27, B:M.31, B:E.61, A:L.24, A:E.61
- Hydrogen bonds: B:Y.35, B:S.168, B:S.168, A:Y.35, A:Y.35
- Water bridges: B:R.20, B:K.169, A:R.20
- Salt bridges: B:R.20, B:K.50, A:R.20, A:H.28
FEC.19: 21 residues within 4Å:- Chain C: R.20, L.24, I.27, H.28, M.31, Y.35, K.50, M.57, E.61
- Chain D: R.20, I.27, H.28, M.31, Y.35, K.50, M.57, E.61, A.167, S.168, K.169
- Ligands: SO4.22
17 PLIP interactions:9 interactions with chain C, 8 interactions with chain D,- Hydrophobic interactions: C:L.24, C:I.27, C:M.31, C:M.57, C:E.61, D:E.61
- Hydrogen bonds: C:Y.35, C:Y.35, D:Y.35, D:S.168, D:S.168, D:K.169
- Salt bridges: C:R.20, C:H.28, D:R.20, D:K.50
- Water bridges: D:R.20
FEC.33: 20 residues within 4Å:- Chain E: R.20, L.24, I.27, H.28, M.31, Y.35, K.50, M.57, E.61
- Chain F: R.20, I.27, H.28, M.31, Y.35, K.50, M.57, E.61, A.167, S.168
- Ligands: SO4.36
15 PLIP interactions:9 interactions with chain E, 6 interactions with chain F,- Hydrophobic interactions: E:L.24, E:I.27, E:I.27, E:M.31, E:E.61, F:I.27, F:E.61
- Hydrogen bonds: E:Y.35, E:Y.35, F:S.168, F:S.168
- Salt bridges: E:R.20, E:H.28, F:R.20, F:K.50
FEC.45: 20 residues within 4Å:- Chain G: R.20, L.24, I.27, H.28, M.31, Y.35, K.50, M.57, R.58, E.61
- Chain H: R.20, H.28, M.31, Y.35, K.50, M.57, E.61, A.167, S.168, K.169
15 PLIP interactions:7 interactions with chain H, 8 interactions with chain G,- Hydrophobic interactions: H:E.61, G:L.24, G:I.27, G:M.31, G:R.58, G:E.61
- Hydrogen bonds: H:Y.35, H:S.168, H:S.168, H:K.169, G:Y.35
- Salt bridges: H:R.20, H:K.50, G:R.20
- Water bridges: G:R.20
FEC.56: 20 residues within 4Å:- Chain I: R.20, L.24, H.28, M.31, Y.35, K.50, M.57, E.61, S.168
- Chain J: R.20, I.27, H.28, M.31, Y.35, K.50, M.57, E.61, A.167, S.168
- Ligands: SO4.60
16 PLIP interactions:7 interactions with chain I, 9 interactions with chain J,- Hydrophobic interactions: I:L.24, I:E.61, J:I.27, J:M.31, J:E.61
- Hydrogen bonds: I:Y.35, I:Y.35, J:S.168, J:S.168
- Water bridges: I:R.20, J:R.20, J:K.169
- Salt bridges: I:R.20, I:H.28, J:R.20, J:K.50
FEC.69: 21 residues within 4Å:- Chain K: R.20, L.24, I.27, H.28, M.31, Y.35, K.50, M.57, E.61
- Chain L: R.20, I.27, H.28, M.31, Y.35, K.50, M.57, E.61, A.167, S.168, K.169
- Ligands: SO4.72
16 PLIP interactions:8 interactions with chain K, 8 interactions with chain L,- Hydrophobic interactions: K:L.24, K:I.27, K:M.31, K:M.57, K:E.61, L:E.61
- Hydrogen bonds: K:Y.35, L:S.168, L:S.168, L:K.169
- Salt bridges: K:R.20, K:H.28, L:R.20, L:K.50
- Water bridges: L:R.20, L:T.164
FEC.83: 20 residues within 4Å:- Chain M: R.20, L.24, I.27, H.28, M.31, Y.35, K.50, M.57, E.61
- Chain N: R.20, I.27, H.28, M.31, Y.35, K.50, M.57, E.61, A.167, S.168
- Ligands: SO4.86
14 PLIP interactions:8 interactions with chain M, 6 interactions with chain N,- Hydrophobic interactions: M:L.24, M:I.27, M:I.27, M:M.31, M:E.61, N:I.27, N:E.61
- Hydrogen bonds: M:Y.35, N:S.168, N:S.168
- Salt bridges: M:R.20, M:H.28, N:R.20, N:K.50
FEC.95: 20 residues within 4Å:- Chain O: R.20, L.24, I.27, H.28, M.31, Y.35, K.50, M.57, R.58, E.61
- Chain P: R.20, H.28, M.31, Y.35, K.50, M.57, E.61, A.167, S.168, K.169
14 PLIP interactions:6 interactions with chain P, 8 interactions with chain O,- Hydrophobic interactions: P:E.61, O:L.24, O:I.27, O:M.31, O:R.58, O:E.61
- Hydrogen bonds: P:S.168, P:S.168, P:K.169, O:Y.35
- Salt bridges: P:R.20, P:K.50, O:R.20
- Water bridges: O:R.20
FEC.106: 20 residues within 4Å:- Chain Q: R.20, L.24, H.28, M.31, Y.35, K.50, M.57, E.61, S.168
- Chain R: R.20, I.27, H.28, M.31, Y.35, K.50, M.57, E.61, A.167, S.168
- Ligands: SO4.110
17 PLIP interactions:7 interactions with chain Q, 10 interactions with chain R,- Hydrophobic interactions: Q:L.24, Q:E.61, R:I.27, R:M.31, R:E.61
- Hydrogen bonds: Q:Y.35, Q:Y.35, R:Y.35, R:S.168, R:S.168
- Water bridges: Q:R.20, R:R.20, R:K.169
- Salt bridges: Q:R.20, Q:H.28, R:R.20, R:K.50
FEC.119: 21 residues within 4Å:- Chain S: R.20, L.24, I.27, H.28, M.31, Y.35, K.50, M.57, E.61
- Chain T: R.20, I.27, H.28, M.31, Y.35, K.50, M.57, E.61, A.167, S.168, K.169
- Ligands: SO4.122
17 PLIP interactions:8 interactions with chain T, 9 interactions with chain S,- Hydrophobic interactions: T:E.61, S:L.24, S:I.27, S:M.31, S:M.57, S:E.61
- Hydrogen bonds: T:S.168, T:S.168, T:K.169, S:Y.35, S:Y.35
- Water bridges: T:R.20, T:T.164
- Salt bridges: T:R.20, T:K.50, S:R.20, S:H.28
FEC.133: 20 residues within 4Å:- Chain U: R.20, L.24, I.27, H.28, M.31, Y.35, K.50, M.57, E.61
- Chain V: R.20, I.27, H.28, M.31, Y.35, K.50, M.57, E.61, A.167, S.168
- Ligands: SO4.136
14 PLIP interactions:8 interactions with chain U, 6 interactions with chain V,- Hydrophobic interactions: U:L.24, U:I.27, U:I.27, U:M.31, U:E.61, V:I.27, V:E.61
- Hydrogen bonds: U:Y.35, V:S.168, V:S.168
- Salt bridges: U:R.20, U:H.28, V:R.20, V:K.50
FEC.145: 20 residues within 4Å:- Chain W: R.20, L.24, I.27, H.28, M.31, Y.35, K.50, M.57, R.58, E.61
- Chain X: R.20, H.28, M.31, Y.35, K.50, M.57, E.61, A.167, S.168, K.169
16 PLIP interactions:7 interactions with chain X, 9 interactions with chain W,- Hydrophobic interactions: X:E.61, W:L.24, W:I.27, W:M.31, W:R.58, W:E.61
- Hydrogen bonds: X:Y.35, X:S.168, X:S.168, X:K.169, W:Y.35, W:Y.35
- Salt bridges: X:R.20, X:K.50, W:R.20
- Water bridges: W:R.20
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Macedo, S. et al., The nature of the di-iron site in the bacterioferritin fromDesulfovibrio desulfuricans. NAT.STRUCT.BIOL. (2003)
- Release Date
- 2003-04-01
- Peptides
- bacterioferritin: ABCDEFGHIJKLMNOPQRSTUVWX
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
GD
HE
IF
JG
MH
NI
AJ
BK
GL
HM
IN
JO
MP
NQ
AR
BS
GT
HU
IV
JW
MX
N
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.05 Å
- Oligo State
- homo-24-mer
- Ligands
- 48 x FE2: FE (II) ION(Non-covalent)
- 90 x SO4: SULFATE ION(Non-functional Binders)
- 12 x FEC: 1,3,5,8-TETRAMETHYL-PORPHINE-2,4,6,7-TETRAPROPIONIC ACID FERROUS COMPLEX(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Macedo, S. et al., The nature of the di-iron site in the bacterioferritin fromDesulfovibrio desulfuricans. NAT.STRUCT.BIOL. (2003)
- Release Date
- 2003-04-01
- Peptides
- bacterioferritin: ABCDEFGHIJKLMNOPQRSTUVWX
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
GD
HE
IF
JG
MH
NI
AJ
BK
GL
HM
IN
JO
MP
NQ
AR
BS
GT
HU
IV
JW
MX
N